Phase 1: Development of a Dual Chemokine CCL2/CCL5 Neutralizing Single-domain Antibody for Treating Non-alcoholic Steatoheptitis
Research Grant
Administered By
Medicine, Gastroenterology
Awarded By
Oncotrap, Inc.
Start Date
September 20, 2023
End Date
August 31, 2025
Administered By
Medicine, Gastroenterology
Awarded By
Oncotrap, Inc.
Start Date
September 20, 2023
End Date
August 31, 2025